Get started
CureVac N.V.CureVac N.V.CureVac N.V.

CureVac N.V.

No trades
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Market insights

CVAC, will pull a NVAX-type surge (x3) soon! CVAC has been under a heavy bear weight this past few months. But it seems like that will change soon. Based on our weekly data metrics a big shift is currently transpiring. The first long term up- shift in almost 12 months has been registered. This is a massive change in trend. We got a break in structure already. More series of ascend will come. Net buying activity has surged significantly conveying position takers are currently active at the present levels in anticipation of weighty future price growth. If you missed the pump of NVAX from 4 to 13.0. CVAC will be your friend for now. Plant your seeds now. Targets are set at 6, then 12.0. Spotted at 3.0 TAYOR.
NASDAQ:CVACLong
by JSAL
7
CVAC - Trade Opportunity Looking through charts, CVAC caught my eye for some potential trade opportunities. Firstly lets look at the candle close of Today 08/01/23 -> We are currently testing this RED Resistance Arrow Line pointing down -> The candle has a lower wick, indicating some buying pressure ->However, the candle body is small, which may indicate waning momentum **If price action CONFIRMS above RED ARROW -> This can be a TRADE SETUP -> If this plays out - TARGET = $10.65 or a potential 17% move -> STOP LOSS should be placed below RED ARROW Notice the GREEN circle indicating a bounce UP from 2 converging support lines -> The 200 DMA -> this is important as if we maintain support on 200 DMA, it indicates Bullish activity, price has a possibility of traveling back to UPPER BLACK RESISTANCE LINE BUT NOTE: This is the first time for CVAC to be doing this, so we have to be cautious, as FAKEOUTS are possible. -> The orange sloping support line ~~ Having 2 support lines converge makes SUPPORT two-folds stronger, which may create ncessary momentum for price to break above RED ARROW Now Notice how the ORANGE SUPPORT LINE coincides with the ORANGE line found on the RSI and MACD -> This is known as a BEARISH DIVEGENCE -> Where price shows a higher low but Indicators show lower lowers. -> This leads to PRICE DECLINES if it plays out, may lead Price Action to go towards the BLACK Support line or where the RED ARROW is pointing at. -> Its also not necessary that it plays out right away, we can technically hit my TARGET of $10.65 and then have the DIVERGENCE play out. *** Regardless of what happens, BLACK SLOPING SUPPORT LINE can be a BUY ZONE with STOP LOSS BELOW this line. This would be to catch a bounce off this line. RSI orange line MUST stay above or act as SUPPORT on the BLACK moving average, this normally leads to PRICE increasing MACD (Momentum indicator) -> must continue this histogram pattern of waning bearish momentum, we must print GREEN histogram. -> There needs to be a BULLISH CROSS where BLUE line crosses above the ORANGE line. -> This would help us breakout of the RED ARROW RESISTANCE STOCH RSI -> BLUE line has CROSSED over ORANGE, and we are ABOVE the 20 level. This indicates BULLISH MOMENTUM. -> We must continue UPWARD above the 80 level, this indicates continuation of MOMENTUM, if we keep this direction -> It may HELP us BREAKOUT of RED ARROW RESISTANCE LINE. CONCLUSION: All in all, we are in a interesting area for CVAC the stock. New things are happening in the price action, that has not been seen in the history of CVAC. 200 DMA acting as support for the 1st time, STOCH RSI Bullish cross and waning of bearish momentum in MACD can be the necessary catalyst to push PRICE above the RED ARROW RESISTANCE. If so TARGET = $10.65 or a 17% Trade. However, it is important to note the BEARISH DIVERGENCE forming, though a sign of DOWNWARD PRICE ACTION, can also lead to opportunity of a trade setup. Never fight the trend, its always better to ride along. Thanks you! Hope this helps, please support my ideas by boosting, following and commenting! Do check out my page of other trade ideas. I have linked a couple of recent ideas ive had, check em out if you'd like. DISCLAIMER: This is not Financial advice, i am NOT a Financial advisor. Thoughts expressed here are my only my opinion and for educational purposes. Do practice due diligence and focus on risk mamangement. Deploy stop losses to protect yourself. Thanks.
NASDAQ:CVAC
by SafofAllTrades
CVAC, BNTX & MRNA comparisonCureVac N.V. (CVAC) has filed a patent infringement lawsuit in Germany against BioNTech to assert the company's intellectual property rights which contributed to COVID-19 vaccine development. The company said the CureVac intellectual property portfolio protects multiple inventions that are considered essential to the design and development of BioNTech's SARS CoV-2 mRNA vaccine, among others (source: Nasdaq). Here's a YTD comparison chart of CVAC, BNTX & MRNA. Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, capital risk management Beware of analyst's motives Emotions & Opinions FOMO : bad timing, the market is ruthless, be shrewd Lack of planning & discipline Forgetting restraint Obdurate repetitive errors, no adaptation 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big, organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum TTC - trend channel AlertiT - notification tickerTracker - MFI Oscillator www.tradingview.com
NASDAQ:CVACLong
by Options360
1
Trading Idea - #CUREVAC (hope for the mutants)THE BIG LONG! Vaccine for the Covid-Mutants! :-) ENTRY: 44.20 EUR TARGET: 90.00 EUR (104 % profit) STOP: 32.40 EUR - This is only an interim analysis result of the CUREVAC Covid vaccince!! - Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues. - The vaccine candidate is in the final stage of clinical development. - CEO Franz-Werner Haas announced that one had hoped for stronger results in the interim analysis. - But continue the current study until the final analysis.
XETR:5CVLong
by Traderherz-Analytics
CureVac's time will comeLook at this. CureVac has been fighting with its resistance at around 80 for quite some time now. But with the next dip, the MA50 will drop below resistance, so in another comeback the breaking of the MA50 could help with the resistance at 80, which after once broken will become a really strong support. Apart from the technicals CureVac is about to release new study results in mid-April, which might give another support. Over all, there lies a great future ahead of this stock.
FWB:5CVLong
by ole_frxrchs